75 results on '"Juergens M"'
Search Results
2. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma
- Author
-
Bröckelmann, P.J., Müller, H., Casasnovas, O., Hutchings, M., von Tresckow, B., Jürgens, M., McCall, S.J., Morschhauser, F., Fuchs, M., Borchmann, P., Moskowitz, C.H., and Engert, A.
- Published
- 2017
- Full Text
- View/download PDF
3. In-vitro-Untersuchungen zur Beurteilung arteriosklerotischer Gefäßsegmente mittels intravaskulären Ultraschalls
- Author
-
Fechtrup, C., Kerber, S., Hasfeld, M., Jürgens, M., Böcker, W., Fahrenkamp, A., Breithardt, G., Heinle, H., editor, Schulte, H., editor, and Schaefer, H. E., editor
- Published
- 1993
- Full Text
- View/download PDF
4. Einfluß der Position intravaskulärer Ultraschallkatheter auf die Wiedergabe von arteriellen Gefäßquerschnitten
- Author
-
Kerber, S., Fechtrup, C., Hasfeld, M., Jürgens, M., Breithardt, G., Fahrenkamp, A., Bäcker, W., Heinle, H., editor, Schulte, H., editor, and Schaefer, H. E., editor
- Published
- 1993
- Full Text
- View/download PDF
5. Experimentelle Evaluierung der kontrastmittelverstärkten, hochauflösenden MR-Angiographie am Tiermodell Gd-DTPA gegenüber Gd-DTPA-Polylysin: Gd-DTPA gegenüber Gd-DTPA-Polylysin
- Author
-
Vogl, T. J., Hoffmann, Y., Juergens, M., Weinmann, H. J., Mühler, A., Yucel, S., and Felix, R.
- Published
- 1996
- Full Text
- View/download PDF
6. MR imaging of head and neck lesions using high-dose gadodiamide injection: a phase III clinical trial
- Author
-
Vogl, T. J., Western, A., Mack, M. G., Kjærsgaard, P., Juergens, M., Balzer, J. O., and Felix, R.
- Published
- 1995
- Full Text
- View/download PDF
7. Production of cephalosporin C by Acremonium chrysogenum in semisynthetic medium
- Author
-
Jürgens, M, Seidel, G, and Schügerl, K
- Published
- 2002
- Full Text
- View/download PDF
8. Effect of sowing date and straw mulch on virus incidence and aphid infestation in organic faba-beans (Vicia faba L.)
- Author
-
Saucke, H., Juergens, M., Döring, Th. F., Lesemann, D.E., Fittje, S., Vetten, H.-J., Saucke, H., Juergens, M., Döring, Th. F., Lesemann, D.E., Fittje, S., and Vetten, H.-J.
- Abstract
The effect of sowing date on aphid infestation and the incidence of aphid-transmitted viruses were investigated in organically managed, small-scale field experiments with two faba bean cultivars over 3 years (2002–04). As an additional factor, strawmulchwas applied in 2 of the 3 years shortly before the start of vector activity in May. Virus incidence was determined using enzyme-linked immunosorbent assay and immunoelectron microscopy. Aphid flight activity was monitored using standard yellow water traps. Bean colonising aphids were assessed throughout the vegetation period by counting the number of plants infested with Acyrthosiphon pisum, Megoura viciae and Aphis fabae. Pea enation mosaic virus and bean yellow mosaic virus were the most abundant aphid-transmitted viruses, being detected in 22–54% and 9–69%, respectively, of the total number of virus-infected plants analysed per year. Further aphid-transmitted viruses found in faba bean were bean leaf roll virus, beet western yellows virus, clover yellow vein virus (in 2002) and soybean dwarf virus (in 2004). A. pisum was the predominant aphid species colonising faba bean plants. Early sowing compared with late sowing led to a significant reduction of the total virus incidence in faba bean in all 3 years. However, significantly decreased levels of A. pisum colonisation as a result of early sowing were observed only in 1 year and one cultivar. Irrespective of sowing date, straw mulching had no significant effects on virus incidence and aphid colonisation. Compared with late sowing, early sowing significantly increased bean yield in all 3 years and kernel weight in 2 years, whereas straw mulching had no effect on yield.
- Published
- 2009
- Full Text
- View/download PDF
9. Comparing steroid estrogen, and nonylphenol content across a range of European sewage plants with different treatment and management practices
- Author
-
Johnson, A.C., Aerni, H.-R., Gerritsen, A., Gibert, M., Giger, W., Hylland, K., Juergens, M., Nakari, T., Pickering, A., Suter, M.J.-F., Svenson, A., Wettstein, F.E., Johnson, A.C., Aerni, H.-R., Gerritsen, A., Gibert, M., Giger, W., Hylland, K., Juergens, M., Nakari, T., Pickering, A., Suter, M.J.-F., Svenson, A., and Wettstein, F.E.
- Abstract
The effluent of 17 sewage treatment works (STW) across Norway, Sweden, Finland, The Netherlands, Belgium, Germany, France and Switzerland was studied for the presence of estradiol (E2), estrone (E1), ethinylestradiol (EE2) and nonylphenol (NP). Treatment processes included primary and chemical treatment only, submerged aerated filter, oxidation ditch, activated sludge (AS) and combined trickling filter with activated sludge. The effluent strength ranged between 87 and 846 L/PE (population equivalent), the total hydraulic retention time (HRT) ranged between 4 and 120 h, sludge retention time (SRT) between 3 and 30 d, and water temperature ranged from 12 to 21 °C. The highest estrogen values were detected in the effluent of the STW which only used primary treatment (13 ng/L E2 and 35 ng/L E1) and on one occasion in one of the STW using the AS system (6.5 ng/L E2, 50.5 ng/L E1, but on three other occasions the concentrations in this STW were at least a factor of 6 lower). For the 16 STW employing secondary treatment E2 was only detected in the effluent of six works during the study period (average 0.7–5.7 ng/L). E1 was detected in the effluent of 13 of the same STW. The median value for E1 for the 16 STW with secondary treatment was 3.0 ng/L. EE2 was only detected in two STW (1.1, <0.8–2.8 ng/L). NP could be detected in the effluent of all 14 STW where this measurement was attempted, with a median of 0.31 μg/L and values ranging from 0.05 to 1.31 μg/L. A comparison of removal performance for E1 was carried out following prediction of the probable influent concentration. A weak but significant (α<5%) correlation between E1 removal and HRT or SRT was observed.
- Published
- 2005
10. Endocrine active industrial chemicals: Release and occurrence in the environment
- Author
-
Johnson, A., Juergens, M., Johnson, A., and Juergens, M.
- Abstract
Of the xenobiotic endocrine active substances (EASs), tributyltin (TBT) has had the clearest link to an impact on aquatic ecology. Its release from marine antifouling paints had a drastic impact on dogwhelk populations in polluted harbors due to a masculization effect. 4-tert-Nonylphenol is seen as the most significant of the industrial xenobiotic estrogen mimics, being implicated as the dominant endocrine disruptor in certain industrialized river reaches. Apart from hot spots associated with particular industries, the estrogenic alkylphenols, phthalates, and bisphenol A are present in effluent and receiving water at concentrations below that which would give cause for concern. Other more bioaccumulative compounds such as polybrominated flame retardants, dioxins, and furans may possess some endocrine active properties. The possibility of additivity effects may yet mean that low concentrations of xenobiotic EASs will need careful consideration. It is noted that considerable quantities of many of these compounds are often found in sewage sludge and sediments.
- Published
- 2003
11. Effect of sowing date and straw mulch on virus incidence and aphid infestation in organically grown faba beans (Vicia faba)
- Author
-
Saucke, H., primary, Juergens, M., additional, Döring, T.F., additional, Fittje, S., additional, Lesemann, D.E., additional, and Vetten, H.J., additional
- Published
- 2009
- Full Text
- View/download PDF
12. Human reactions to good and bad robots
- Author
-
Broadbent, E., primary, MacDonald, B., additional, Jago, L., additional, Juergens, M., additional, and Mazharullah, O., additional
- Published
- 2007
- Full Text
- View/download PDF
13. Traumatische Parese des N. facialis und N. cochlearis: Vergleichende Darstellung in der MRT und CT
- Author
-
Mack, M., primary, Vogl, Th., additional, Tykocinski, M., additional, Balzer, J., additional, Pegios, W., additional, Juergens, M., additional, Dahm, M., additional, and Felix, R., additional
- Published
- 1997
- Full Text
- View/download PDF
14. MR-guided laser-induced thermotherapy of head and neck tumors
- Author
-
Mack, Martin G., primary, Vogl, Thomas J., additional, Mueller, Petra, additional, Philipp, Carsten M., additional, Boettcher, H., additional, Roggan, Andre, additional, Juergens, M., additional, Pegios, W., additional, Scholz, W. R., additional, Balzer, J. O., additional, Jahnke, V., additional, and Felix, Roland, additional
- Published
- 1996
- Full Text
- View/download PDF
15. MR-gesteuerte laserinduzierte Thermotherapie bei Tumoren in der Kopf-Hals-Region: Erste klinische Ergebnisse
- Author
-
Vogl, Th., primary, Mack, M., additional, Müller, Petra, additional, Philipp, C., additional, Juergens, M., additional, Knöbber, D., additional, Roggan, A., additional, Wust, P., additional, Jahnke, V., additional, and Felix, R., additional
- Published
- 1995
- Full Text
- View/download PDF
16. Recurrent nasopharyngeal tumors: preliminary clinical results with interventional MR imaging--controlled laser-induced thermotherapy.
- Author
-
Vogl, T J, primary, Mack, M G, additional, Müller, P, additional, Phillip, C, additional, Böttcher, H, additional, Roggan, A, additional, Juergens, M, additional, Deimling, M, additional, Knöbber, D, additional, and Wust, P, additional
- Published
- 1995
- Full Text
- View/download PDF
17. Mehrvolumen-MR-Angiographie der A. carotis interna: Eine präoperative Vergleichsstudie
- Author
-
Vagi, Th., primary, Heinzinger, K., additional, Juergens, M., additional, Kutter, H., additional, Hepp, W., additional, Balzer, J., additional, Haupt, G., additional, Banzer, D., additional, and Felix:, R., additional
- Published
- 1995
- Full Text
- View/download PDF
18. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
- Author
-
Vogl, T J, primary, Mack, M G, additional, Juergens, M, additional, Stark, M, additional, Pegios, W, additional, Bergman, C, additional, Grevers, G, additional, and Western, A, additional
- Published
- 1994
- Full Text
- View/download PDF
19. Glomus tumors of the skull base: combined use of MR angiography and spin-echo imaging.
- Author
-
Vogl, T J, primary, Juergens, M, additional, Balzer, J O, additional, Mack, M G, additional, Bergman, C, additional, Grevers, G, additional, Lissner, J, additional, and Felix, R, additional
- Published
- 1994
- Full Text
- View/download PDF
20. Fettunterdrückung in der kontrastverstärkten MRT der Schädelbasis und der Kopf-Hals-Region: Klinische Wertigkeit
- Author
-
Vogl, Th., primary, Mack, M., additional, Juergens, M., additional, Stark, M., additional, Deimling, M., additional, Knöbber, W., additional, Grevers, G., additional, and Felix, R., additional
- Published
- 1994
- Full Text
- View/download PDF
21. Skull base tumors: gadodiamide injection--enhanced MR imaging--drop-out effect in the early enhancement pattern of paragangliomas versus different tumors.
- Author
-
Vogl, T J, primary, Mack, M G, additional, Juergens, M, additional, Bergman, C, additional, Grevers, G, additional, Jacobsen, T F, additional, Lissner, J, additional, and Felix, R, additional
- Published
- 1993
- Full Text
- View/download PDF
22. MR-Angiographie für die Tumordiagnostik in der Kopf-Hals-Region
- Author
-
Vogl, Th., primary, Balzer, J., additional, Juergens, M., additional, Grevers, G., additional, and Lissner, J., additional
- Published
- 1992
- Full Text
- View/download PDF
23. S31 Mucosal healing in Crohn's disease is associated with high infliximab trough levels
- Author
-
Van Moerkercke, W., Compernolle, G., Ackaert, C., Gils, A., Vermeire, S., Jürgens, M., Cleynen, I., van Assche, G., and Rutgeerts, P.
- Published
- 2010
- Full Text
- View/download PDF
24. P230 - Ethnic differences in the genetic susceptibility to Crohn's disease: functional PPARγ gene variants are not associated with susceptibility to inflammatory bowel disease in the German population
- Author
-
Seiderer, J., Glas, J., Diegelmann, J., Markus, C., Pfennig, S., Tillack, C., Jürgens, M., Konrad, A., Wetzke, M., Paschos, E., Török, H., Griga, T., Klein, W., Epplen, J.T., Schiemann, U., Mussack, T., Lohse, P., Göke, B., Folwaczny, M., Ochsenkühn, T., Müller-Myhsok, B., and Brand, S.
- Published
- 2009
- Full Text
- View/download PDF
25. P216 - The first two Crohn's disease susceptibility loci with a high degree of epistasis: PTGER4-expression-modulating polymorphisms in the 5p13.1 region enhance ATG16L1-associated susceptibility to Crohn's disease
- Author
-
Seiderer, J., Glas, J., Diegelmann, J., Pasciuto, G., Tillack, C., Roeske, D., Pfennig, S., Jürgens, M., Konrad, A., TÖrök, H., Griga, T., Klein, W., Epplen, J.T., Schiemann, U., Mussack, T., Lohse, P., Göke, B., Ochsenkühn, T., Folwaczny, M., Müller-Myhsok, B., and Brand, S.
- Published
- 2009
- Full Text
- View/download PDF
26. P220 - The NOD2 variants rs2066843 and rs2076756 are novel independent Crohn's disease susceptibility gene variants associated with severe penetrating disease phenotype resulting in frequent need for surgery
- Author
-
Seiderer, J., Glas, J., Diegelmann, J., Pasciuto, G., Tillack, C., Pfennig, S., Jürgens, M., Konrad, A., Török, H., Schiemann, U., Griga, T., Klein, W., Epplen, J.T., Mussack, T., Lohse, P., Göke, B., Ochsenkühn, T., Folwaczny, M., Müller-Myhsok, B., and Brand, S.
- Published
- 2009
- Full Text
- View/download PDF
27. P191 - Efficacy and safety in the use of infliximab in ulcerative colitis: analysis of a large single center cohort
- Author
-
Jürgens, M., Brand, S., Laubender, R.T., Weidinger, M., Hartl, F., Seiderer, J., Glas, J., Stallhofer, J., Beigel, F., Wetzke, M., Pfennig, S., Tillack, C., Schnitzler, F., Göke, B., and Ochsenkühn, T.
- Published
- 2009
- Full Text
- View/download PDF
28. P130 THE FREQUENCY OF ANAPHYLACTIC REACTIONS IN THE USE OF INFLIXIMAB IN A LARGE SINGLE CENTER - A PROSPECTIVE STUDY
- Author
-
Jürgens, M., Tillack, C., Seiderer, J., Pfennig, S., Göke, B., Brand, S., and Ochsenkühn, T.
- Published
- 2008
- Full Text
- View/download PDF
29. P075 IS PRESENCE OF FISTULAS A PREDICTOR FOR INTESTINAL STENOSES ?
- Author
-
Jürgens, M., Brand, S., Seiderer, J., Herrmann, K., Tillack, C., Pfennig, S., Kreis, M., Göke, B., and Ochsenkühn, T.
- Published
- 2008
- Full Text
- View/download PDF
30. New insights in the structure and biology of the high affinity receptor for IgE (FceRI) on human epidermal Langerhans cells
- Author
-
Bieber, T., Kraft, S., Juergens, M., Strobel, I., Haberstok, J., Tomov, H., Regele, D., Salle, H. De la, Wollenberg, A., and Hanau, D.
- Published
- 1996
- Full Text
- View/download PDF
31. Matrix-assisted laser desorption/ionisation mass spectrometry guided purification of human guanylin from blood ultrafiltrate
- Author
-
Schrader, M., Juergens, M., Hess, R., Schulz-Knappe, P., Raida, M., and Forssmann, W.-G.
- Published
- 1997
- Full Text
- View/download PDF
32. Peptide bank generated by large-scale preparation of circulating human peptides
- Author
-
Schulz-Knappe, P., Schrader, M., Staendker, L., Richter, R., Hess, R., Juergens, M., and Forssmann, W.-G.
- Published
- 1997
- Full Text
- View/download PDF
33. Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of Age.
- Author
-
Griffin I, Irving SA, Arriola CS, Campbell AP, Li DK, Dawood FS, Doughty-Skierski C, Ferber JR, Ferguson N, Hadden L, Henderson JT, Juergens M, Kancharla V, Naleway AL, Newes-Adeyi G, Nicholson E, Odouli R, Reichle L, Sanyang M, Woodworth K, and Munoz FM
- Subjects
- Pregnancy, Child, Infant, Humans, Female, Adolescent, Infant, Newborn, Incidence, SARS-CoV-2, COVID-19 Testing, Risk Factors, COVID-19 epidemiology, Pregnancy Complications, Infectious prevention & control
- Abstract
Background: Studies suggest infants may be at increased risk of severe coronavirus disease 2019 (COVID-19) relative to older children, but few data exist regarding the incidence of COVID-19 episodes and associated risk factors. We estimate incidence rates and describe characteristics associated with medically attended COVID-19 episodes among infants younger than 6 months of age., Methods: We analyzed electronic medical record data from a cohort of infants born March 1, 2020-February 28, 2021. Data from 3 health care delivery systems included demographic characteristics, maternal and infant outpatient visit and hospitalization diagnoses and severe acute respiratory syndrome coronavirus syndrome 2 (SARS-CoV-2) test results. Medically attended COVID-19 episodes were defined by positive SARS-CoV-2 clinical tests and/or COVID-19 diagnosis codes during medical care visits. Unadjusted and site-adjusted incidence rates by infant month of age, low and high SARS-CoV-2 circulation periods and maternal COVID-19 diagnosis were calculated., Results: Among 18,192 infants <6 months of age whose mothers received prenatal care within the 3 systems, 173 (1.0%) had medically attended COVID-19 episodes. Incidence rates were highest among infants under 1 month of age (2.0 per 1000 person-weeks) and 1 month (2.0 per 1000 person-weeks) compared with older infants. Incidence rates were also higher for infants born to women with postpartum COVID-19 compared with women without known COVID-19 and women diagnosed with COVID-19 during pregnancy., Conclusions: Infants of women with postpartum COVID-19 had a higher risk of medically attended COVID-19 than infants born to mothers who were diagnosed during pregnancy or never diagnosed underscoring the importance of COVID-19 prevention measures for their household members and caregivers to prevent infections in infants., Competing Interests: A.L.N. reports institutional support from Pfizer and Vir Biotechnology. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). The other authors have no conflicts of interest to disclose., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
34. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020-February 2021.
- Author
-
Delahoy MJ, Munoz F, Li DK, Arriola CS, Bond NL, Daugherty M, Ferber J, Ferguson N, Hadden L, Henderson JT, Irving SA, Juergens M, Kancharla V, Greenberg M, Odouli R, Newes-Adeyi G, Nicholson EG, Reichle L, Sanyang M, Snead M, Dawood FS, and Naleway AL
- Subjects
- Infant, Newborn, Female, Pregnancy, Humans, SARS-CoV-2, COVID-19 Testing, Cross-Sectional Studies, Peripartum Period, Hospitalization, COVID-19 diagnosis, COVID-19 epidemiology, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology
- Abstract
Background: Identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during peripartum hospitalizations is important to guide care, implement prevention measures, and understand infection burden., Methods: This cross-sectional analysis used electronic health record data from hospitalizations during which pregnancies ended (peripartum hospitalizations) among a cohort of pregnant persons at 3 US integrated healthcare networks (sites 1-3). Maternal demographic, medical encounter, SARS-CoV-2 testing, and pregnancy and neonatal outcome information was extracted for persons with estimated delivery and pregnancy end dates during March 2020-February 2021 and ≥1 antenatal care record. Site-stratified multivariable logistic regression was used to identify factors associated with testing and compare pregnancy and neonatal outcomes among persons tested., Results: Among 17 858 pregnant persons, 10 863 (60.8%) had peripartum SARS-CoV-2 testing; 222/10 683 (2.0%) had positive results. Testing prevalence varied by site and was lower during March-May 2020. Factors associated with higher peripartum SARS-CoV-2 testing odds were Asian race (adjusted odds ratio [aOR]: 1.36; 95% confidence interval [CI]: 1.03-1.79; referent: White) (site 1), Hispanic or Latino ethnicity (aOR: 1.33; 95% CI: 1.08-1.64) (site 2), peripartum Medicaid coverage (aOR: 1.33; 95% CI: 1.06-1.66) (site 1), and preterm hospitalization (aOR: 1.69; 95% CI: 1.19-2.39 [site 1]; aOR: 1.39; 95% CI: 1.03-1.88 [site 2])., Conclusions: Findings highlight potential disparities in SARS-CoV-2 peripartum testing by demographic and pregnancy characteristics. Testing practice variations should be considered when interpreting studies relying on convenience samples of pregnant persons testing positive for SARS-CoV-2. Efforts to address testing differences between groups could improve equitable testing practices and care for pregnant persons with SARS-CoV-2 infections., Competing Interests: Potential conflicts of interest. A. L. N. received research funding from Pfizer and Vir Biotechnology for unrelated studies (paid to their institution). F. M. participates on data safety monitoring boards for Pfizer (includes a stipend for the author), Moderna (paid to author), Meissa (includes a stipend for the author), Virometix (unpaid participation), and the National Institutes of Health (unpaid participation) and reports grants or contracts from Pfizer (Pediatric COVID-19 Vaccine Study; payment to their institution), Gilead (Pediatric Remdesivir Study; payment to their institution), and the National Institutes of Health (COVID-19 vaccines in pregnant women and Acute Flacid Myelitis Natural History Study; payment to their institution) and royalties or licenses for Up to Date on various chapters and editing (paid to author). M. G. reports several internal grants from Kaiser Permanente Northern California Division of Research for research funding (paid to their institution). M. S. reports other financial or nonfinancial interests from the CDC as a government employee who performed co-authorship duties as part of regular employment. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.)
- Published
- 2023
- Full Text
- View/download PDF
35. Assessment of contaminants of emerging concern in European apex predators and their prey by LC-QToF MS wide-scope target analysis.
- Author
-
Gkotsis G, Nika MC, Nikolopoulou V, Alygizakis N, Bizani E, Aalizadeh R, Badry A, Chadwick E, Cincinelli A, Claßen D, Danielsson S, Dekker R, Duke G, Drost W, Glowacka N, Göckener B, Jansman HAH, Juergens M, Knopf B, Koschorreck J, Krone O, Martellini T, Movalli P, Persson S, Potter ED, Rohner S, Roos A, O' Rourke E, Siebert U, Treu G, van den Brink NW, Walker LA, Williams R, Slobodnik J, and Thomaidis NS
- Subjects
- Europe, Mass Spectrometry
- Abstract
Apex predators are good indicators of environmental pollution since they are relatively long-lived and their high trophic position and spatiotemporal exposure to chemicals provides insights into the persistent, bioaccumulative and toxic (PBT) properties of chemicals. Although monitoring data from apex predators can considerably support chemicals' management, there is a lack of pan-European studies, and longer-term monitoring of chemicals in organisms from higher trophic levels. The present study investigated the occurrence of contaminants of emerging concern (CECs) in 67 freshwater, marine and terrestrial apex predators and in freshwater and marine prey, gathered from four European countries. Generic sample preparation protocols for the extraction of CECs with a broad range of physicochemical properties and the purification of the extracts were used. The analysis was performed utilizing liquid (LC) chromatography coupled to high resolution mass spectrometry (HRMS), while the acquired chromatograms were screened for the presence of more than 2,200 CECs through wide-scope target analysis. In total, 145 CECs were determined in the apex predator and their prey samples belonging in different categories, such as pharmaceuticals, plant protection products, per- and polyfluoroalkyl substances, their metabolites and transformation products. Higher concentration levels were measured in predators compared to prey, suggesting that biomagnification of chemicals through the food chain occurs. The compounds were prioritized for further regulatory risk assessment based on their frequency of detection and their concentration levels. The majority of the prioritized CECs were lipophilic, although the presence of more polar contaminants should not be neglected. This indicates that holistic analytical approaches are required to fully characterize the chemical universe of biota samples. Therefore, the present survey is an attempt to systematically investigate the presence of thousands of chemicals at a European level, aiming to use these data for better chemicals management and contribute to EU Zero Pollution Ambition., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
36. Medically Attended Influenza During Pregnancy in the 2019-2020 and 2020-2021 Influenza Seasons.
- Author
-
Irving SA, Shuster E, Henderson JT, Li DK, Ferber J, Odouli R, Munoz FM, Nicholson E, Hadden L, Juergens M, Newes-Adeyi G, Reichle L, Arriola CS, Dawood FS, Daugherty M, Wielgosz K, and Naleway AL
- Subjects
- Humans, Pregnancy, Female, United States epidemiology, Pandemics, Seasons, SARS-CoV-2, Retrospective Studies, Influenza, Human diagnosis, Influenza, Human epidemiology, COVID-19 epidemiology
- Abstract
Influenza testing and case-confirmation rates in pregnant populations have not been reported during the coronavirus disease 2019 (COVID-19) pandemic. Using electronic medical record data from a cohort of nearly 20,000 pregnancies in the United States, this retrospective cohort study examines the frequency of acute respiratory or febrile illness encounters, influenza testing, and influenza positivity during the 2020-2021 influenza season, which occurred during the COVID-19 pandemic, compared with the 2019-2020 influenza season, which largely did not. The ratios of influenza tests to acute respiratory or febrile illness visits were similar in the 2019-2020 and 2020-2021 influenza seasons (approximately 1:8 and 1:9, respectively) but were low and varied by study site. Although influenza testing in pregnant patients continued in the 2020-2021 season, when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulation was widespread in the United States, no cases of influenza were identified in our study cohort., Competing Interests: Financial Disclosure Flor M. Munoz disclosed that money was paid to their institution from NIH, Pfizer, Gilead, and the CDC. They received payment from DSMB Moderna and royalties from UpToDate. Erin Nicholson received payment from Novavax. Allison L. Naleway's institution received funding from Pfizer and Vir Biotechnology for unrelated studies. Ms. Hadden, Ms. Juergens, Dr. Newes-Adeyi, and Mr. Reichle conducted this work through their employment with Abt Associates. The other authors did not report any potential conflicts of interest., (Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
37. Association between Fruit and Vegetable Consumption and Depression Symptoms in Young People and Adults Aged 15-45: A Systematic Review of Cohort Studies.
- Author
-
Dharmayani PNA, Juergens M, Allman-Farinelli M, and Mihrshahi S
- Subjects
- Adolescent, Adult, Cohort Studies, Depression epidemiology, Diet, Humans, Middle Aged, Prospective Studies, Young Adult, Fruit, Vegetables
- Abstract
Higher consumption of fruit and vegetables has been associated with a lower risk of various chronic diseases including coronary heart disease, obesity, and certain cancers. Recently, fruit and vegetable intake has also been linked with mental health, including depression; however, this area is largely unexplored studies in young people and adults. This systematic review aimed to evaluate the association between fruit and vegetable intake and depressive symptoms in young people and adults aged 15-45. The review used a predefined protocol registered with International Prospective Register of Systematic Reviews (PROSPERO) database (ID no: CRD42018091642). The systematic review focused on peer-reviewed cohort studies published from 1 January 2000 to 31 August 2020 using searches of six electronic databases. The exposure was fruit and vegetable consumption analysed both separately and/or together, and the outcome was depression or depressive symptoms. Data from eligible studies were extracted according to predefined criteria and the studies were appraised using the Newcastle-Ottawa Scale (NOS) for cohort studies to evaluate for study quality and risk of bias. A total of 12 studies from seven countries were deemed eligible and included in the qualitative synthesis, one study was categorised as "very good" quality, nine studies were "good" quality, and two studies were "moderate" quality by the quality assessment based on the total score for the NOS. The majority of cohort studies support the evidence that fruit consumption is associated with decreased risk of developing depression. However, the inconsistent results were observed when the effects of vegetable consumption were analysed independently, and the effects of fruit and vegetables combined were analysed. Despite this, the evidence seems to be building that a possible association exists, and this may have implications for addressing the burden of mental illness in young people and adults aged 15-45 years. More well-designed prospective cohort studies are needed to provide more robust evidence on the relationship between fruit and vegetable intake and depression.
- Published
- 2021
- Full Text
- View/download PDF
38. Comparing the outcomes of two independent computed tomography perfusion softwares and their impact on therapeutic decisions in acute ischemic stroke.
- Author
-
Bathla G, Ortega-Gutierrez S, Klotz E, Juergens M, Zevallos CB, Ansari S, Ward CE, Policeni B, Samaniego E, and Derdeyn C
- Subjects
- Aged, Brain Ischemia therapy, Female, Humans, Male, Middle Aged, Perfusion Imaging trends, Prospective Studies, Retrospective Studies, Stroke therapy, Thrombectomy methods, Thrombectomy trends, Tomography, X-Ray Computed trends, Triage methods, Triage trends, Brain Ischemia diagnostic imaging, Clinical Decision-Making methods, Perfusion Imaging methods, Software trends, Stroke diagnostic imaging, Tomography, X-Ray Computed methods
- Abstract
Background: To compare the computed tomography perfusion (CTP) outcomes derived from two commercial CTP processing software and evaluate their concordance in terms of eligibility for mechanical thrombectomy (MT) in acute ischemic stroke (AIS), based on DEFUSE III criteria., Methods: A total of 118 patients (62 patients in the MT group and 56 patients in the non-MT (NMT) group) were included. Volumetric perfusion outputs were compared between Syngo.via (package A) and RAPID (package B). Influence on proceeding or not-proceeding with MT was based on DEFUSE III imaging eligibility criteria., Results: Median core infarct/hypoperfusion volumes were 12.3/126 mL in the MT group and 7.7/29.3 ml in the NMT group with package A and 10.5/138 mL and 1.9/24.5 mL with package B, respectively. In the MT group (n=62), concordant perfusion results in terms of patient triage were noted in all but two cases. Of these, one patient would not have qualified (low ASPECTS), while the other qualified based on package A results. For the NMT group (n=56), there was discordance in terms of MT eligibility in seven cases. However, none of these patients qualified for MT based on DEFUSE III criteria., Conclusions: Both perfusion softwares showed high concordance in correctly triaging patients in the MT versus NMT groups (110/118, 93.2%), which further improved when all DEFUSE III imaging criteria were considered (117/118, 99.1%). The core/hypoperfusion volumes in the NMT group and core infarct volumes in the MT groups were comparable. The hypoperfusion volumes in the MT group varied slightly but did not affect triage between groups., Competing Interests: Competing interests: EK and MJ are full-time employees of Siemens AG, Forchheim, Germany., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
39. Achieving comparable perfusion results across vendors. The next step in standardizing stroke care: a technical report.
- Author
-
Bathla G, Limaye K, Policeni B, Klotz E, Juergens M, and Derdeyn C
- Subjects
- Adult, Aged, Aged, 80 and over, Brain Ischemia physiopathology, Cerebrovascular Circulation physiology, Female, Humans, Image Processing, Computer-Assisted methods, Male, Middle Aged, Perfusion Imaging methods, Retrospective Studies, Stroke physiopathology, Tomography, X-Ray Computed methods, Brain Ischemia diagnostic imaging, Image Processing, Computer-Assisted standards, Perfusion Imaging standards, Software standards, Stroke diagnostic imaging, Tomography, X-Ray Computed standards
- Abstract
Background: The role of mechanical thrombectomy in acute ischemic stroke (AIS) has been further expanded by recent trials which relied on the results of CT perfusion (CTP) imaging. However, CTP parameters for ischemia and infarct can vary significantly across different vendors., Methods: We compared the outcomes of the Siemens CTP software against the clinically validated RAPID software in 45 consecutive patients with suspected AIS. Both perfusion softwares initially processed images using vendor defined parameters for hypoperfusion and non-viable tissue. The software thresholds on the Siemens software were decrementally altered to see if concordant results between softwares could be attained., Results: At baseline settings, the mean values for core infarct and hypoperfusion were different (mean of 30/69 mL, respectively, for RAPID and 49/77 mL for Siemens). However, reducing the threshold values for the later software showed a concordance of values at a relative cerebral blood flow <20%, with resulting core infarct and hypoperfusion volumes at 31/69 mL, respectively, for the Siemens software. A Wilcoxon paired test showed no significant difference between the calculated core infarct and hypoperfusion values, both for the entire population as well as for the subgroup of patients with large vessel occlusion., Conclusion: Equivalent CTP results between vendor softwares may be attainable by altering the thresholds for hypoperfused and non-viable tissue, despite differences in acquisition techniques, post-processing, and scanners., Competing Interests: Competing interests: EK and MJ are full time employees of Siemens AG, Forchheim, Germany., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
40. Integrate Classroom Physical Activity in Schools.
- Author
-
Chen BH, Michael S, Borgogna B, Holmes K, Hughes K, Jew L, and Juergens M
- Published
- 2019
- Full Text
- View/download PDF
41. Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
- Author
-
Leung W, Shaffer CD, Reed LK, Smith ST, Barshop W, Dirkes W, Dothager M, Lee P, Wong J, Xiong D, Yuan H, Bedard JE, Machone JF, Patterson SD, Price AL, Turner BA, Robic S, Luippold EK, McCartha SR, Walji TA, Walker CA, Saville K, Abrams MK, Armstrong AR, Armstrong W, Bailey RJ, Barberi CR, Beck LR, Blaker AL, Blunden CE, Brand JP, Brock EJ, Brooks DW, Brown M, Butzler SC, Clark EM, Clark NB, Collins AA, Cotteleer RJ, Cullimore PR, Dawson SG, Docking CT, Dorsett SL, Dougherty GA, Downey KA, Drake AP, Earl EK, Floyd TG, Forsyth JD, Foust JD, Franchi SL, Geary JF, Hanson CK, Harding TS, Harris CB, Heckman JM, Holderness HL, Howey NA, Jacobs DA, Jewell ES, Kaisler M, Karaska EA, Kehoe JL, Koaches HC, Koehler J, Koenig D, Kujawski AJ, Kus JE, Lammers JA, Leads RR, Leatherman EC, Lippert RN, Messenger GS, Morrow AT, Newcomb V, Plasman HJ, Potocny SJ, Powers MK, Reem RM, Rennhack JP, Reynolds KR, Reynolds LA, Rhee DK, Rivard AB, Ronk AJ, Rooney MB, Rubin LS, Salbert LR, Saluja RK, Schauder T, Schneiter AR, Schulz RW, Smith KE, Spencer S, Swanson BR, Tache MA, Tewilliager AA, Tilot AK, VanEck E, Villerot MM, Vylonis MB, Watson DT, Wurzler JA, Wysocki LM, Yalamanchili M, Zaborowicz MA, Emerson JA, Ortiz C, Deuschle FJ, DiLorenzo LA, Goeller KL, Macchi CR, Muller SE, Pasierb BD, Sable JE, Tucci JM, Tynon M, Dunbar DA, Beken LH, Conturso AC, Danner BL, DeMichele GA, Gonzales JA, Hammond MS, Kelley CV, Kelly EA, Kulich D, Mageeney CM, McCabe NL, Newman AM, Spaeder LA, Tumminello RA, Revie D, Benson JM, Cristostomo MC, DaSilva PA, Harker KS, Jarrell JN, Jimenez LA, Katz BM, Kennedy WR, Kolibas KS, LeBlanc MT, Nguyen TT, Nicolas DS, Patao MD, Patao SM, Rupley BJ, Sessions BJ, Weaver JA, Goodman AL, Alvendia EL, Baldassari SM, Brown AS, Chase IO, Chen M, Chiang S, Cromwell AB, Custer AF, DiTommaso TM, El-Adaimi J, Goscinski NC, Grove RA, Gutierrez N, Harnoto RS, Hedeen H, Hong EL, Hopkins BL, Huerta VF, Khoshabian C, LaForge KM, Lee CT, Lewis BM, Lydon AM, Maniaci BJ, Mitchell RD, Morlock EV, Morris WM, Naik P, Olson NC, Osterloh JM, Perez MA, Presley JD, Randazzo MJ, Regan MK, Rossi FG, Smith MA, Soliterman EA, Sparks CJ, Tran DL, Wan T, Welker AA, Wong JN, Sreenivasan A, Youngblom J, Adams A, Alldredge J, Bryant A, Carranza D, Cifelli A, Coulson K, Debow C, Delacruz N, Emerson C, Farrar C, Foret D, Garibay E, Gooch J, Heslop M, Kaur S, Khan A, Kim V, Lamb T, Lindbeck P, Lucas G, Macias E, Martiniuc D, Mayorga L, Medina J, Membreno N, Messiah S, Neufeld L, Nguyen SF, Nichols Z, Odisho G, Peterson D, Rodela L, Rodriguez P, Rodriguez V, Ruiz J, Sherrill W, Silva V, Sparks J, Statton G, Townsend A, Valdez I, Waters M, Westphal K, Winkler S, Zumkehr J, DeJong RJ, Hoogewerf AJ, Ackerman CM, Armistead IO, Baatenburg L, Borr MJ, Brouwer LK, Burkhart BJ, Bushhouse KT, Cesko L, Choi TY, Cohen H, Damsteegt AM, Darusz JM, Dauphin CM, Davis YP, Diekema EJ, Drewry M, Eisen ME, Faber HM, Faber KJ, Feenstra E, Felzer-Kim IT, Hammond BL, Hendriksma J, Herrold MR, Hilbrands JA, Howell EJ, Jelgerhuis SA, Jelsema TR, Johnson BK, Jones KK, Kim A, Kooienga RD, Menyes EE, Nollet EA, Plescher BE, Rios L, Rose JL, Schepers AJ, Scott G, Smith JR, Sterling AM, Tenney JC, Uitvlugt C, VanDyken RE, VanderVennen M, Vue S, Kokan NP, Agbley K, Boham SK, Broomfield D, Chapman K, Dobbe A, Dobbe I, Harrington W, Ibrahem M, Kennedy A, Koplinsky CA, Kubricky C, Ladzekpo D, Pattison C, Ramirez RE Jr, Wande L, Woehlke S, Wawersik M, Kiernan E, Thompson JS, Banker R, Bartling JR, Bhatiya CI, Boudoures AL, Christiansen L, Fosselman DS, French KM, Gill IS, Havill JT, Johnson JL, Keny LJ, Kerber JM, Klett BM, Kufel CN, May FJ, Mecoli JP, Merry CR, Meyer LR, Miller EG, Mullen GJ, Palozola KC, Pfeil JJ, Thomas JG, Verbofsky EM, Spana EP, Agarwalla A, Chapman J, Chlebina B, Chong I, Falk IN, Fitzgibbons JD, Friedman H, Ighile O, Kim AJ, Knouse KA, Kung F, Mammo D, Ng CL, Nikam VS, Norton D, Pham P, Polk JW, Prasad S, Rankin H, Ratliff CD, Scala V, Schwartz NU, Shuen JA, Xu A, Xu TQ, Zhang Y, Rosenwald AG, Burg MG, Adams SJ, Baker M, Botsford B, Brinkley B, Brown C, Emiah S, Enoch E, Gier C, Greenwell A, Hoogenboom L, Matthews JE, McDonald M, Mercer A, Monsma N, Ostby K, Ramic A, Shallman D, Simon M, Spencer E, Tomkins T, Wendland P, Wylie A, Wolyniak MJ, Robertson GM, Smith SI, DiAngelo JR, Sassu ED, Bhalla SC, Sharif KA, Choeying T, Macias JS, Sanusi F, Torchon K, Bednarski AE, Alvarez CJ, Davis KC, Dunham CA, Grantham AJ, Hare AN, Schottler J, Scott ZW, Kuleck GA, Yu NS, Kaehler MM, Jipp J, Overvoorde PJ, Shoop E, Cyrankowski O, Hoover B, Kusner M, Lin D, Martinov T, Misch J, Salzman G, Schiedermayer H, Snavely M, Zarrasola S, Parrish S, Baker A, Beckett A, Belella C, Bryant J, Conrad T, Fearnow A, Gomez C, Herbstsomer RA, Hirsch S, Johnson C, Jones M, Kabaso R, Lemmon E, Vieira CM, McFarland D, McLaughlin C, Morgan A, Musokotwane S, Neutzling W, Nietmann J, Paluskievicz C, Penn J, Peoples E, Pozmanter C, Reed E, Rigby N, Schmidt L, Shelton M, Shuford R, Tirasawasdichai T, Undem B, Urick D, Vondy K, Yarrington B, Eckdahl TT, Poet JL, Allen AB, Anderson JE, Barnett JM, Baumgardner JS, Brown AD, Carney JE, Chavez RA, Christgen SL, Christie JS, Clary AN, Conn MA, Cooper KM, Crowley MJ, Crowley ST, Doty JS, Dow BA, Edwards CR, Elder DD, Fanning JP, Janssen BM, Lambright AK, Lane CE, Limle AB, Mazur T, McCracken MR, McDonough AM, Melton AD, Minnick PJ, Musick AE, Newhart WH, Noynaert JW, Ogden BJ, Sandusky MW, Schmuecker SM, Shipman AL, Smith AL, Thomsen KM, Unzicker MR, Vernon WB, Winn WW, Woyski DS, Zhu X, Du C, Ament C, Aso S, Bisogno LS, Caronna J, Fefelova N, Lopez L, Malkowitz L, Marra J, Menillo D, Obiorah I, Onsarigo EN, Primus S, Soos M, Tare A, Zidan A, Jones CJ, Aronhalt T, Bellush JM, Burke C, DeFazio S, Does BR, Johnson TD, Keysock N, Knudsen NH, Messler J, Myirski K, Rekai JL, Rempe RM, Salgado MS, Stagaard E, Starcher JR, Waggoner AW, Yemelyanova AK, Hark AT, Bertolet A, Kuschner CE, Parry K, Quach M, Shantzer L, Shaw ME, Smith MA, Glenn O, Mason P, Williams C, Key SC, Henry TC, Johnson AG, White JX, Haberman A, Asinof S, Drumm K, Freeburg T, Safa N, Schultz D, Shevin Y, Svoronos P, Vuong T, Wellinghoff J, Hoopes LL, Chau KM, Ward A, Regisford EG, Augustine L, Davis-Reyes B, Echendu V, Hales J, Ibarra S, Johnson L, Ovu S, Braverman JM, Bahr TJ, Caesar NM, Campana C, Cassidy DW, Cognetti PA, English JD, Fadus MC, Fick CN, Freda PJ, Hennessy BM, Hockenberger K, Jones JK, King JE, Knob CR, Kraftmann KJ, Li L, Lupey LN, Minniti CJ, Minton TF, Moran JV, Mudumbi K, Nordman EC, Puetz WJ, Robinson LM, Rose TJ, Sweeney EP, Timko AS, Paetkau DW, Eisler HL, Aldrup ME, Bodenberg JM, Cole MG, Deranek KM, DeShetler M, Dowd RM, Eckardt AK, Ehret SC, Fese J, Garrett AD, Kammrath A, Kappes ML, Light MR, Meier AC, O'Rouke A, Perella M, Ramsey K, Ramthun JR, Reilly MT, Robinett D, Rossi NL, Schueler MG, Shoemaker E, Starkey KM, Vetor A, Vrable A, Chandrasekaran V, Beck C, Hatfield KR, Herrick DA, Khoury CB, Lea C, Louie CA, Lowell SM, Reynolds TJ, Schibler J, Scoma AH, Smith-Gee MT, Tuberty S, Smith CD, Lopilato JE, Hauke J, Roecklein-Canfield JA, Corrielus M, Gilman H, Intriago S, Maffa A, Rauf SA, Thistle K, Trieu M, Winters J, Yang B, Hauser CR, Abusheikh T, Ashrawi Y, Benitez P, Boudreaux LR, Bourland M, Chavez M, Cruz S, Elliott G, Farek JR, Flohr S, Flores AH, Friedrichs C, Fusco Z, Goodwin Z, Helmreich E, Kiley J, Knepper JM, Langner C, Martinez M, Mendoza C, Naik M, Ochoa A, Ragland N, Raimey E, Rathore S, Reza E, Sadovsky G, Seydoux MI, Smith JE, Unruh AK, Velasquez V, Wolski MW, Gosser Y, Govind S, Clarke-Medley N, Guadron L, Lau D, Lu A, Mazzeo C, Meghdari M, Ng S, Pamnani B, Plante O, Shum YK, Song R, Johnson DE, Abdelnabi M, Archambault A, Chamma N, Gaur S, Hammett D, Kandahari A, Khayrullina G, Kumar S, Lawrence S, Madden N, Mandelbaum M, Milnthorp H, Mohini S, Patel R, Peacock SJ, Perling E, Quintana A, Rahimi M, Ramirez K, Singhal R, Weeks C, Wong T, Gillis AT, Moore ZD, Savell CD, Watson R, Mel SF, Anilkumar AA, Bilinski P, Castillo R, Closser M, Cruz NM, Dai T, Garbagnati GF, Horton LS, Kim D, Lau JH, Liu JZ, Mach SD, Phan TA, Ren Y, Stapleton KE, Strelitz JM, Sunjed R, Stamm J, Anderson MC, Bonifield BG, Coomes D, Dillman A, Durchholz EJ, Fafara-Thompson AE, Gross MJ, Gygi AM, Jackson LE, Johnson A, Kocsisova Z, Manghelli JL, McNeil K, Murillo M, Naylor KL, Neely J, Ogawa EE, Rich A, Rogers A, Spencer JD, Stemler KM, Throm AA, Van Camp M, Weihbrecht K, Wiles TA, Williams MA, Williams M, Zoll K, Bailey C, Zhou L, Balthaser DM, Bashiri A, Bower ME, Florian KA, Ghavam N, Greiner-Sosanko ES, Karim H, Mullen VW, Pelchen CE, Yenerall PM, Zhang J, Rubin MR, Arias-Mejias SM, Bermudez-Capo AG, Bernal-Vega GV, Colon-Vazquez M, Flores-Vazquez A, Gines-Rosario M, Llavona-Cartagena IG, Martinez-Rodriguez JO, Ortiz-Fuentes L, Perez-Colomba EO, Perez-Otero J, Rivera E, Rodriguez-Giron LJ, Santiago-Sanabria AJ, Senquiz-Gonzalez AM, delValle FR, Vargas-Franco D, Velázquez-Soto KI, Zambrana-Burgos JD, Martinez-Cruzado JC, Asencio-Zayas L, Babilonia-Figueroa K, Beauchamp-Pérez FD, Belén-Rodríguez J, Bracero-Quiñones L, Burgos-Bula AP, Collado-Méndez XA, Colón-Cruz LR, Correa-Muller AI, Crooke-Rosado JL, Cruz-García JM, Defendini-Ávila M, Delgado-Peraza FM, Feliciano-Cancela AJ, Gónzalez-Pérez VM, Guiblet W, Heredia-Negrón A, Hernández-Muñiz J, Irizarry-González LN, Laboy-Corales ÁL, Llaurador-Caraballo GA, Marín-Maldonado F, Marrero-Llerena U, Martell-Martínez HA, Martínez-Traverso IM, Medina-Ortega KN, Méndez-Castellanos SG, Menéndez-Serrano KC, Morales-Caraballo CI, Ortiz-DeChoudens S, Ortiz-Ortiz P, Pagán-Torres H, Pérez-Afanador D, Quintana-Torres EM, Ramírez-Aponte EG, Riascos-Cuero C, Rivera-Llovet MS, Rivera-Pagán IT, Rivera-Vicéns RE, Robles-Juarbe F, Rodríguez-Bonilla L, Rodríguez-Echevarría BO, Rodríguez-García PM, Rodríguez-Laboy AE, Rodríguez-Santiago S, Rojas-Vargas ML, Rubio-Marrero EN, Santiago-Colón A, Santiago-Ortiz JL, Santos-Ramos CE, Serrano-González J, Tamayo-Figueroa AM, Tascón-Peñaranda EP, Torres-Castillo JL, Valentín-Feliciano NA, Valentín-Feliciano YM, Vargas-Barreto NM, Vélez-Vázquez M, Vilanova-Vélez LR, Zambrana-Echevarría C, MacKinnon C, Chung HM, Kay C, Pinto A, Kopp OR, Burkhardt J, Harward C, Allen R, Bhat P, Chang JH, Chen Y, Chesley C, Cohn D, DuPuis D, Fasano M, Fazzio N, Gavinski K, Gebreyesus H, Giarla T, Gostelow M, Greenstein R, Gunasinghe H, Hanson C, Hay A, He TJ, Homa K, Howe R, Howenstein J, Huang H, Khatri A, Kim YL, Knowles O, Kong S, Krock R, Kroll M, Kuhn J, Kwong M, Lee B, Lee R, Levine K, Li Y, Liu B, Liu L, Liu M, Lousararian A, Ma J, Mallya A, Manchee C, Marcus J, McDaniel S, Miller ML, Molleston JM, Diez CM, Ng P, Ngai N, Nguyen H, Nylander A, Pollack J, Rastogi S, Reddy H, Regenold N, Sarezky J, Schultz M, Shim J, Skorupa T, Smith K, Spencer SJ, Srikanth P, Stancu G, Stein AP, Strother M, Sudmeier L, Sun M, Sundaram V, Tazudeen N, Tseng A, Tzeng A, Venkat R, Venkataram S, Waldman L, Wang T, Yang H, Yu JY, Zheng Y, Preuss ML, Garcia A, Juergens M, Morris RW, Nagengast AA, Azarewicz J, Carr TJ, Chichearo N, Colgan M, Donegan M, Gardner B, Kolba N, Krumm JL, Lytle S, MacMillian L, Miller M, Montgomery A, Moretti A, Offenbacker B, Polen M, Toth J, Woytanowski J, Kadlec L, Crawford J, Spratt ML, Adams AL, Barnard BK, Cheramie MN, Eime AM, Golden KL, Hawkins AP, Hill JE, Kampmeier JA, Kern CD, Magnuson EE, Miller AR, Morrow CM, Peairs JC, Pickett GL, Popelka SA, Scott AJ, Teepe EJ, TerMeer KA, Watchinski CA, Watson LA, Weber RE, Woodard KA, Barnard DC, Appiah I, Giddens MM, McNeil GP, Adebayo A, Bagaeva K, Chinwong J, Dol C, George E, Haltaufderhyde K, Haye J, Kaur M, Semon M, Serjanov D, Toorie A, Wilson C, Riddle NC, Buhler J, Mardis ER, and Elgin SC
- Subjects
- Animals, Codon, Computational Biology, DNA Transposable Elements, Drosophila melanogaster genetics, Exons, Gene Rearrangement, Heterochromatin, Introns, Molecular Sequence Annotation, Polytene Chromosomes, Repetitive Sequences, Nucleic Acid, Selection, Genetic, Species Specificity, Drosophila genetics, Drosophila Proteins genetics, Evolution, Molecular, Genome, Genomics
- Abstract
The Muller F element (4.2 Mb, ~80 protein-coding genes) is an unusual autosome of Drosophila melanogaster; it is mostly heterochromatic with a low recombination rate. To investigate how these properties impact the evolution of repeats and genes, we manually improved the sequence and annotated the genes on the D. erecta, D. mojavensis, and D. grimshawi F elements and euchromatic domains from the Muller D element. We find that F elements have greater transposon density (25-50%) than euchromatic reference regions (3-11%). Among the F elements, D. grimshawi has the lowest transposon density (particularly DINE-1: 2% vs. 11-27%). F element genes have larger coding spans, more coding exons, larger introns, and lower codon bias. Comparison of the Effective Number of Codons with the Codon Adaptation Index shows that, in contrast to the other species, codon bias in D. grimshawi F element genes can be attributed primarily to selection instead of mutational biases, suggesting that density and types of transposons affect the degree of local heterochromatin formation. F element genes have lower estimated DNA melting temperatures than D element genes, potentially facilitating transcription through heterochromatin. Most F element genes (~90%) have remained on that element, but the F element has smaller syntenic blocks than genome averages (3.4-3.6 vs. 8.4-8.8 genes per block), indicating greater rates of inversion despite lower rates of recombination. Overall, the F element has maintained characteristics that are distinct from other autosomes in the Drosophila lineage, illuminating the constraints imposed by a heterochromatic milieu., (Copyright © 2015 Leung et al.)
- Published
- 2015
- Full Text
- View/download PDF
42. The global phosphoproteome of Chlamydomonas reinhardtii reveals complex organellar phosphorylation in the flagella and thylakoid membrane.
- Author
-
Wang H, Gau B, Slade WO, Juergens M, Li P, and Hicks LM
- Subjects
- Chromatography, Liquid, Phosphorylation, Polymers, Proteomics, Tandem Mass Spectrometry, Titanium, Algal Proteins metabolism, Chlamydomonas reinhardtii metabolism, Flagella metabolism, Phosphoproteins metabolism, Thylakoids metabolism
- Abstract
Chlamydomonas reinhardtii is the most intensively-studied and well-developed model for investigation of a wide-range of microalgal processes ranging from basic development through understanding triacylglycerol production. Although proteomic technologies permit interrogation of these processes at the protein level and efforts to date indicate phosphorylation-based regulation of proteins in C. reinhardtii is essential for its underlying biology, characterization of the C. reinhardtii phosphoproteome has been limited. Herein, we report the richest exploration of the C. reinhardtii proteome to date. Complementary enrichment strategies were used to detect 4588 phosphoproteins distributed among every cellular component in C. reinhardtii. Additionally, we report 18,160 unique phosphopeptides at <1% false discovery rate, which comprise 15,862 unique phosphosites - 98% of which are novel. Given that an estimated 30% of proteins in a eukaryotic cell are subject to phosphorylation, we report the majority of the phosphoproteome (23%) of C. reinhardtii. Proteins in key biological pathways were phosphorylated, including photosynthesis, pigment production, carbon assimilation, glycolysis, and protein and carbohydrate metabolism, and it is noteworthy that hyperphosphorylation was observed in flagellar proteins. This rich data set is available via ProteomeXchange (ID: PXD000783) and will significantly enhance understanding of a range of regulatory mechanisms controlling a variety of cellular process and will serve as a critical resource for the microalgal community., (© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
43. Structure of soybean β-cyanoalanine synthase and the molecular basis for cyanide detoxification in plants.
- Author
-
Yi H, Juergens M, and Jez JM
- Subjects
- Catalytic Domain, Crystallography, X-Ray, Cysteine Synthase chemistry, Cysteine Synthase metabolism, Inactivation, Metabolic, Lyases genetics, Models, Molecular, Mutation, Protein Conformation, Glycine max drug effects, Glycine max enzymology, Substrate Specificity, Cyanides pharmacokinetics, Lyases chemistry, Lyases metabolism, Glycine max metabolism
- Abstract
Plants produce cyanide (CN-) during ethylene biosynthesis in the mitochondria and require β-cyanoalanine synthase (CAS) for CN- detoxification. Recent studies show that CAS is a member of the β-substituted alanine synthase (BSAS) family, which also includes the Cys biosynthesis enzyme O-acetylserine sulfhydrylase (OASS), but how the BSAS evolved distinct metabolic functions is not understood. Here we show that soybean (Glycine max) CAS and OASS form α-aminoacrylate reaction intermediates from Cys and O-acetylserine, respectively. To understand the molecular evolution of CAS and OASS in the BSAS enzyme family, the crystal structures of Gm-CAS and the Gm-CAS K95A mutant with a linked pyridoxal phosphate (PLP)-Cys molecule in the active site were determined. These structures establish a common fold for the plant BSAS family and reveal a substrate-induced conformational change that encloses the active site for catalysis. Comparison of CAS and OASS identified residues that covary in the PLP binding site. The Gm-OASS T81M, S181M, and T185S mutants altered the ratio of OASS:CAS activity but did not convert substrate preference to that of a CAS. Generation of a triple mutant Gm-OASS successfully switched reaction chemistry to that of a CAS. This study provides new molecular insight into the evolution of diverse enzyme functions across the BSAS family in plants.
- Published
- 2012
- Full Text
- View/download PDF
44. Transgenic soybean plants overexpressing O-acetylserine sulfhydrylase accumulate enhanced levels of cysteine and Bowman-Birk protease inhibitor in seeds.
- Author
-
Kim WS, Chronis D, Juergens M, Schroeder AC, Hyun SW, Jez JM, and Krishnan HB
- Subjects
- Amino Acid Sequence, Base Sequence, Cysteine Synthase biosynthesis, Cysteine Synthase genetics, Gene Dosage, Gene Expression Regulation, Plant, Genes, Plant, Genetic Engineering, Genetic Variation, Molecular Sequence Data, Plants, Genetically Modified enzymology, Plants, Genetically Modified genetics, Plants, Genetically Modified metabolism, Seeds chemistry, Seeds enzymology, Seeds genetics, Seeds metabolism, Soybean Proteins biosynthesis, Soybean Proteins genetics, Soybean Proteins metabolism, Glycine max chemistry, Glycine max enzymology, Glycine max genetics, Cysteine biosynthesis, Cysteine Synthase metabolism, Glycine max metabolism, Trypsin Inhibitor, Bowman-Birk Soybean metabolism
- Abstract
Soybeans provide an excellent source of protein in animal feed. Soybean protein quality can be enhanced by increasing the concentration of sulfur-containing amino acids. Previous attempts to increase the concentration of sulfur-containing amino acids through the expression of heterologous proteins have met with limited success. Here, we report a successful strategy to increase the cysteine content of soybean seed through the overexpression of a key sulfur assimilatory enzyme. We have generated several transgenic soybean plants that overexpress a cytosolic isoform of O-acetylserine sulfhydrylase (OASS). These transgenic soybean plants exhibit a four- to tenfold increase in OASS activity when compared with non-transformed wild-type. The OASS activity in the transgenic soybeans was significantly higher at all the stages of seed development. Unlike the non-transformed soybean plants, there was no marked decrease in the OASS activity even at later stages of seed development. Overexpression of cytosolic OASS resulted in a 58-74% increase in protein-bound cysteine levels compared with non-transformed wild-type soybean seeds. A 22-32% increase in the free cysteine levels was also observed in transgenic soybeans overexpressing OASS. Furthermore, these transgenic soybean plants showed a marked increase in the accumulation of Bowman-Birk protease inhibitor, a cysteine-rich protein. The overall increase in soybean total cysteine content (both free and protein-bound) satisfies the recommended levels required for the optimal growth of monogastric animals.
- Published
- 2012
- Full Text
- View/download PDF
45. Genetic analyses of the host-pathogen system Turnip yellows virus (TuYV)-rapeseed (Brassica napus L.) and development of molecular markers for TuYV-resistance.
- Author
-
Juergens M, Paetsch C, Krämer I, Zahn M, Rabenstein F, Schondelmaier J, Schliephake E, Snowdon R, Friedt W, and Ordon F
- Subjects
- Amplified Fragment Length Polymorphism Analysis, Brassica rapa virology, Chromosomes, Plant, Genetic Markers, Brassica rapa genetics, Brassica rapa immunology, Luteoviridae, Plant Diseases genetics, Plant Diseases immunology
- Abstract
The aphid transmitted Turnip yellows virus (TuYV) has become a serious pathogen in many rapeseed (Brassica napus L.) growing areas. Three-years' field trials were carried out to get detailed information on the genetics of TuYV resistance derived from the resynthesised B. napus line 'R54' and to develop closely linked markers. F(1) plants and segregating doubled-haploid (DH) populations derived from crosses to susceptible cultivars were analysed using artificial inoculation with virus-bearing aphids, followed by DAS-ELISA. Assuming a threshold of E (405) = 0.1 in ELISA carried out in December, the results led to the conclusion that pre-winter inhibition of TuYV is inherited in a monogenic dominant manner. However, the virus titre in most resistant lines increased during the growing period, indicating that the resistance is incomplete and that the level of the virus titre is influenced by environmental factors. Bulked-segregant marker analysis for this resistance locus identified two closely linked SSR markers along with six closely linked and three co-segregating AFLP markers. Two AFLP markers were converted into co-dominant STS markers, facilitating efficient marker-based selection for TuYV resistance. Effective markers are particularly valuable with respect to breeding for TuYV resistance, because artificial inoculation procedures using virus-bearing aphids are extremely difficult to integrate into practical rapeseed breeding programs.
- Published
- 2010
- Full Text
- View/download PDF
46. Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs.
- Author
-
Fiegl M, Lindner LH, Juergens M, Eibl H, Hiddemann W, and Braess J
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cell Survival drug effects, Dose-Response Relationship, Drug, Drug Interactions, Drug Resistance, Neoplasm, Drug Screening Assays, Antitumor, Female, HL-60 Cells, Humans, Male, Middle Aged, Organophosphates administration & dosage, Organophosphates therapeutic use, Quaternary Ammonium Compounds administration & dosage, Quaternary Ammonium Compounds therapeutic use, Antineoplastic Combined Chemotherapy Protocols pharmacology, Apoptosis drug effects, Leukemia, Myeloid, Acute drug therapy, Leukemia, Myeloid, Acute pathology, Organophosphates pharmacology, Quaternary Ammonium Compounds pharmacology
- Abstract
Purpose: Alkylphosphocholines represent a new class of cytostatic drugs with a novel mode of action. Erufosine (ErPC3), the first compound of this class that can be administered intravenously, has recently been shown to be active against human tumor and leukemic cell lines., Methods: In order to evaluate the antileukemic potential of ErPC3 in acute myeloid leukemia (AML) the lethal concentration 50% (LC 50) was determined using WST-1 assay. For analysis of cell death, staining for Annexin V and activated caspase 3 was performed. An interaction analysis was performed by calculation of combination index and construction of isobolograms., Results: The LC 50 was 7.4 microg/ml after 24 h and 3.2 microg/ml after 72 h in HL 60 cells and 30.1 and 8.6 microg/ml, respectively, in 19 fresh samples from patients with AML. ErPC3 was found to be cytotoxic in HL60 cells with distinct activation of caspase 3. ErPC3 was not cross-resistant with cytarabine, idarubicine and etoposide as shown by the linear relation of respective LC 50s. The latter agents, however, exerted an additive cytotoxicity in combination with ErPC3 as revealed by isobologram analysis and combination index, although results are uneven for idarubicine., Conclusion: Based on these data ErPC3 appears as a novel antileukemic candidate drug, which needs to be explored further in the treatment of AML.
- Published
- 2008
- Full Text
- View/download PDF
47. Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.
- Author
-
Fiegl M, Juergens M, Hiddemann W, and Braess J
- Subjects
- Acute Disease, Aged, Bone Marrow Cells drug effects, Bone Marrow Cells metabolism, Caspase 3 metabolism, Cell Proliferation drug effects, Cytarabine pharmacology, Drug Screening Assays, Antitumor, Drug Therapy, Combination, Female, Flow Cytometry, Granulocyte Colony-Stimulating Factor administration & dosage, Granulocyte-Macrophage Colony-Stimulating Factor administration & dosage, HL-60 Cells drug effects, Humans, Leukemia, Myeloid metabolism, Leukemia, Myeloid pathology, Male, Middle Aged, Zoledronic Acid, Antineoplastic Agents therapeutic use, Diphosphonates therapeutic use, Imidazoles therapeutic use, Leukemia, Myeloid drug therapy
- Abstract
The third-generation bisphosphonate zoledronic acid (ZOL) has recently been shown to be active against human tumour and leukemic cell lines. The purpose of this study was to evaluate the antileukemic potential of ZOL in acute myeloid leukemia (AML). We determined the lethal concentration 50% (LC 50) using the WST-1 assay of ZOL as being 287.9 microg/ml after 24 h and 108.3 microg/ml after 96 h in HL 60 cells and to be 382.4 and 43.2 microg/ml, respectively, in nine samples from patients with AML. The ZOL induced inhibition of proliferative activity of HL 60 cells could not be abrogated by the hematopetic growth factors G-CSF and GM-CSF. ZOL was found to by cytotoxic in HL 60 cells without activation of caspase 3. ZOL was not cross resistant with cytarabine as shown by the linear correlation of LC 50s. Both agents, however, exerted an additive cytotoxicity as revealed by isobologram-analysis and combination index. These data warrant further investigation of ZOL in the treatment of AML.
- Published
- 2007
- Full Text
- View/download PDF
48. High-throughput biomarker discovery and identification by mass spectrometry.
- Author
-
Menzel C, Guillou V, Kellmann M, Khamenya V, Juergens M, and Schulz-Knappe P
- Subjects
- Chromatography, High Pressure Liquid, Humans, Peptide Library, Spectrometry, Mass, Electrospray Ionization, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Biomarkers analysis, Drug Evaluation, Preclinical methods
- Abstract
Native peptides and proteins are of increasing interest in biomedical research because they hold promise to represent a large number of useful diagnostic and therapeutic biomarkers. Discovery attempts from patient samples have to deal with the complexity of biology from a disease perspective as well as with a high individual variability. High throughput screening of samples is therefore the strategy of choice to detect relevant peptidic biomarkers, and requires a high order of automation particularly in the detection process. In this contribution, a novel technical approach employing a fully automated MALDI-TOF/TOF mass spectrometer is described. This approach combines high throughput biomarker discovery with the identification of corresponding endogenous peptides in one instrument and from the same set of samples. The degree of automation allows the analysis of thousands of chromatographic fractions corresponding to up to one hundred patient samples per day. The applied relative quantification via Differential Peptide Display((R)) is performed in a label-free way and shows a dynamic range of up to four orders of magnitude in the accessible peptide concentrations. The typical limit of detection is in the mid- to low-picomolar range for body fluids such as blood plasma, urine and cerebrospinal fluid. Sequence assignment via MALDI-TOF/TOF mass spectrometry is carried out either in an overview approach, characterizing rapidly the peptide composition e.g. of a novel sample, or in a directed approach, analyzing a list of biomarker candidates deduced from statistically significant abundance differences from the biomarker discovery process.
- Published
- 2005
- Full Text
- View/download PDF
49. [Traumatic paresis of the n. facialis and n. cochlearis: its comparative imaging in MRT and CT].
- Author
-
Mack MG, Vogl TJ, Tykocinski M, Balzer JO, Pegios W, Juergens M, Dahm MC, and Felix R
- Subjects
- Accidental Falls, Adult, Facial Paralysis etiology, Humans, Male, Time Factors, Vestibulocochlear Nerve Diseases diagnosis, Vestibulocochlear Nerve Diseases etiology, Cochlear Nerve diagnostic imaging, Cochlear Nerve injuries, Cochlear Nerve pathology, Facial Nerve diagnostic imaging, Facial Nerve pathology, Facial Nerve Injuries, Facial Paralysis diagnosis, Magnetic Resonance Imaging, Tomography, X-Ray Computed
- Published
- 1997
- Full Text
- View/download PDF
50. [Perioperative evaluation of internal carotid artery stenoses: value of multislab MR angiography].
- Author
-
Vogl TJ, Kutter RW, Schön K, Juergens M, Hepp W, Balzer JO, Steger W, and Felix R
- Subjects
- Adult, Aged, Aged, 80 and over, Angiography, Digital Subtraction, Blood Vessel Prosthesis, Carotid Stenosis surgery, Cerebral Angiography, Cerebral Revascularization, Endarterectomy, Carotid, Female, Follow-Up Studies, Humans, Male, Middle Aged, Postoperative Complications diagnosis, Sensitivity and Specificity, Treatment Outcome, Carotid Stenosis diagnosis, Magnetic Resonance Angiography instrumentation
- Abstract
Purpose: Evaluation of the diagnostic potential of high resolution multislab 3D-TOF-magnetic resonance angiography (MRA) in the pre- and postoperative assessment of carotid artery stenosis in comparison to conventional angiography., Methods: 120 Patients were evaluated with MRA and DSA prior to carotid endarterectomy (CEA). Additionally 26 patients underwent MRA after CEA. All MRA examinations were carried out on a 1.5 T MR-unit (Siemens Magnetom SP63) using a Helmholtz surface coil. For the visualization of the vascular structures in the head and neck region, flow compensated GE-sequences were employed. Both original MRA data set and MIP angiograms were included in the evaluation. The determination of the extent of stenoses was performed according to the recommendation of NASCET., Results: In 195 (92.9%) of 210 cases included in the review MRA revealed the same results as DSA (grade I+II: 114, grade III: 24, grade IV: 44, grade V: 13). None of the cases showed a deviation higher than one grade. The sensitivity and specificity of hemodynamic relevant stenoses (> 60%) was 0.964 respectively 0.952. 23 out of 26 patients with postoperative follow-up examination revealed regular reperfusion of the former affected internal carotid artery. The remaining 3 patients showed a restenosis of the operated vessel (n = 2) and a reocclusion of the ICA after surgery (n = 1). MRA proofed to be an accurate and reliable method for the perioperative evaluation of vascular structures in the head and neck region. Despite of some drawbacks MRA reached a high accuracy in the diagnostic imaging before and after CEA. MRA is accurate and useful in screening carotid artery diseases. The indication of MRA employment therefore not only covers the screening of vascular structures but also includes pre- and postoperative evaluation of vascular stenoses.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.